Using PET/CT imaging can help clinicians detect recurrent thyroid disease among patients who have negative radioiodine scans.
PET/CT can accurately detect recurrent thyroid disease not demonstrated by radioiodine scans, according to a presentation that will be given in September at the Royal College of Radiologists Annual Scientific Meeting, which will be held in London, UK.
Researchers sought to determine the usefulness of PET/CT in detecting recurrent thyroid disease in patients who had a negative thyroid scan, but raised serum thyroglobulin levels. They performed a three-year retrospective study that involved 23 patients (average age, 54.2) who had thyroid cancer. All patients had a negative radioiodine scan and raised serum thyroglobulin levels.
All patients (11 males, 12 females) underwent PET/CT examination. The researchers found that for 12 patients (52.2 percent), the PET/CT detected recurrent thyroid lesions or distant metastases that had not been seen on radioiodine studies. There was also a statistically significant difference in the serum thyroglobulin levels between patients who were found to have positive lesions and those who did not have lesions.
The researchers concluded that the PET/CT imaging could accurately detect recurrent thyroid disease that was not found with radioiodine scans.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.